These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6024840)

  • 1. Response of guinea pig to sublethal x-irradiation and live tularemia vaccine.
    Nutter JE; Eigelsbach HT
    Proc Soc Exp Biol Med; 1967 Apr; 124(4):1227-30. PubMed ID: 6024840
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of immunobiological activity of Francisella tularensis C-complex preparations as promising component of subunit vaccines].
    Volokh OA; Shepelev IA; Firsova VV; Khramkova EM; Avdeeva NG; Samokhvalova IuI; Eremin SA; Diatlov IA; Zhemchugov VE
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (3):16-21. PubMed ID: 17672125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host-parasite relationship in monkeys administered live tularemia vaccine.
    Tulis JJ; Eigelsbach HT; Kerpsack RW
    Am J Pathol; 1970 Feb; 58(2):329-36. PubMed ID: 4985427
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental substantiation of the possibility of aerosol immunization with a live tularemia vaccine].
    Agafonov VI; Gapochko KG; Libikh I; Misnikov OP; Erikhleb M
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Sep; (9):33-6. PubMed ID: 747027
    [No Abstract]   [Full Text] [Related]  

  • 5. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background.
    Chen W; Shen H; Webb A; KuoLee R; Conlan JW
    Vaccine; 2003 Sep; 21(25-26):3690-700. PubMed ID: 12922099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Morphometric characteristics of tularemia infectious process in the organism of immunized guinea pigs].
    Bugorkova SA; Emelina DG
    Zh Mikrobiol Epidemiol Immunobiol; 2012; (1):76-9. PubMed ID: 22442975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of sublethal x-irradiation on immuity of guinea pigs administered live tularemia vaccine.
    Nutter JE; Guss ML
    Proc Soc Exp Biol Med; 1967 Nov; 126(2):450-2. PubMed ID: 6079921
    [No Abstract]   [Full Text] [Related]  

  • 8. [The protective properties of the outer membranes of Francisella tularensis in an experimental infection in guinea pigs].
    Khlebnikov VS; Golovlev IR; Chugunov AM; Zhemchugov VE; Averin SF; Afanas'ev SS; Pshirkov SIu; Konovalov SI; Stepanov AV
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (1):84-8. PubMed ID: 8184621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
    Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination strategies for Francisella tularensis.
    Isherwood KE; Titball RW; Davies DH; Felgner PL; Morrow WJ
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1403-14. PubMed ID: 15919131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen.
    Shen H; Chen W; Conlan JW
    Vaccine; 2004 Jun; 22(17-18):2116-21. PubMed ID: 15149767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive Immunity to
    Roberts LM; Powell DA; Frelinger JA
    Front Cell Infect Microbiol; 2018; 8():115. PubMed ID: 29682484
    [No Abstract]   [Full Text] [Related]  

  • 14. Tularemia vaccines: recent developments and remaining hurdles.
    Conlan JW
    Future Microbiol; 2011 Apr; 6(4):391-405. PubMed ID: 21526941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse model of oral infection with virulent type A Francisella tularensis.
    KuoLee R; Zhao X; Austin J; Harris G; Conlan JW; Chen W
    Infect Immun; 2007 Apr; 75(4):1651-60. PubMed ID: 17242058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine potencies of the live vaccine strain of Francisella tularensis and isolated bacterial components.
    Hambleton P; Evans CG; Hood AM; Strange RE
    Br J Exp Pathol; 1974 Aug; 55(4):363-73. PubMed ID: 4215444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells.
    Griffin AJ; Crane DD; Wehrly TD; Bosio CM
    Clin Vaccine Immunol; 2015 Jan; 22(1):119-28. PubMed ID: 25410207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent
    Jia Q; Horwitz MA
    Front Cell Infect Microbiol; 2018; 8():154. PubMed ID: 29868510
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy of tularemia: characterization of a monoclonal antibody reactive with Francisella tularensis.
    Narayanan RB; Drabick JJ; Williams JC; Fortier AH; Meltzer MS; Sadoff JC; Bolt CR; Nacy CA
    J Leukoc Biol; 1993 Jan; 53(1):112-6. PubMed ID: 8426087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of the immunizing effect of the virulent Tularemia strain treated by streptomycin].
    Brikman DI
    Antibiotiki; 1971 Sep; 16(9):827-31. PubMed ID: 5139456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.